Assistance Publique Hôpitaux de Marseille
Marseille, 13005, France
NCT Number: NCT04897659
This study aimed to evaluate incidence, prognosis and predictive factors of new-onset of persistent left bundle branch block (LBBB) after rapid-deployment aortic valve replacement (RD-AVR) with the IntuityTM bioprosthesis.
It was an observational, retrospective and single-center study. Two hundred and seventy-four consecutive patients without any baseline ventricular conduction disorder or previous permanent pacemaker or defibrillator implantation who underwent RD-AVR with the IntuityTM valve were included. Twelve-lead electrocardiogram and transthoracic echocardiography were performed preoperatively, postoperatively, at discharge, 1-month, and 1-year. Incidence, prognosis and predictive factors of new-onset of persistent LBBB were evaluated.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Marseille, 13005, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: at 1 year
QRS duration ≥ 120 ms with QS or rS patterns on the V1 lead, a large notched R wave in D1, aVL, V5 and V6 and the absence of Q wave in V5 and V6, according to the recommendations of the American Heart Association. NOP-LBBB was persistence of LBBB on the 12-lead recording electrocardiogram (ECG) at discharge from hospital.
Assistance Publique Hopitaux De Marseille
Other
Persistent Left Bundle Branch Block After Rapid-Deployment Aortic Valve Replacement: Incidence, Long-term Prognostic and Predictive Factors
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00465218
Aortic Valve Disease, Brain Diseases
Ottawa, Ontario, Canada
View Trial DetailsNCT04909424
Aortic Valve Disease, Cardiovascular Diseases
Toulouse, France
View Trial DetailsNCT06106451
Aortic Valve Disease, Aortic Valve Replacement
Baltimore, Maryland, United States
View Trial DetailsNCT01194362
Aortic Valve Disease, Cardiovascular Diseases
Plano, Texas, United States
View Trial Details